Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Mthfr 677C>T and 1298A>C Genetic Polymorphisms With Colorectal Cancer: Genotype and Haplotype Analysis in a Southeast Iranian Population Publisher



Yari A1, 2 ; Meybodi SME1, 2 ; Karam ZM2, 3 ; Samoudi A1, 4 ; Hashemi F4 ; Aalipour M5 ; Abadi MFS4 ; Dabiri S4, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Department of Medical Genetics, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  3. 3. Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
  4. 4. Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Clinical Pathology, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Source: Gene Reports Published:2021


Abstract

Background: The methylenetetrahydrofolate reductase (MTHFR) gene is involved in DNA methylation, synthesis and repair, which influences the risk of cancers. Many studies have demonstrated that the MTHFR rs1801133 and rs1801131 polymorphisms are linked with the risks of colorectal cancer (CRC). However, no study has probed the relationship between these polymorphisms and CRC risk in southeast Iranian population. Therefore, the aim of this study was to investigate the association of these two polymorphisms with CRC risk in a case-control investigation. Methods: A total of 200 confirmed CRC patients and 200 healthy controls (matched to sex and age) were recruited from the Southeast of Iran between 2014 and 2019. Genomic DNA was extracted and genotyped for the polymorphisms using the polymerase chain reaction-restriction fragment length polymorphism method. The relationship between the polymorphism and CRC risk was evaluated by logistical regression analysis. Results: MTHFR 667C>T polymorphism was significantly associated with a lower risk of CRC (TT vs CC: p-value = 0.021; CT vs CC: p-value = 0.047; CT+TT vs CC: p-value = 0.017). The T-allele was associated with decreased risk for CRC (p-value = 0.012). However, we did not observe any association of 1298A>C with CRC. Furthermore, stratified analysis showed that MTHFR 667C>T polymorphism was correlated with tumor location in CRC patients. The frequency of T-A haplotype was significantly higher in the healthy controls compared to CRC patients (p-value = 0.021). Conclusion: In conclusion, the T-allele of MTHFR 667C>T polymorphism was related to decreased susceptibility to CRC in this Iranian population. Moreover, the CT-AA and TT-AA combined genotypes and T-A haplotype of MTHFR 667C>T and 1298A>C polymorphisms were associated with decreased risk of CRC. © 2021 Elsevier Inc.